Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C023514 |
2,6-dinitrotoluene |
2,6-dinitrotoluene results in decreased expression of ACAD11 mRNA | decreases expression | 20406850
|
C472791 |
3-(4'-hydroxy-3'-adamantylbiphenyl-4-yl)acrylic acid |
3-(4'-hydroxy-3'-adamantylbiphenyl-4-yl)acrylic acid results in increased expression of ACAD11 mRNA | increases expression | 16788091
|
D016604 |
Aflatoxin B1 |
Aflatoxin B1 affects the expression of ACAD11 protein | affects expression | 20106945
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in decreased expression of ACAD11 mRNA | decreases expression | 20106945
|
D002251 |
Carbon Tetrachloride |
Carbon Tetrachloride affects the expression of ACAD11 mRNA | affects expression | 17484886
|
D016572 |
Cyclosporine |
Cyclosporine results in decreased expression of ACAD11 mRNA | decreases expression | 20106945
|
C023036 |
perfluorooctanoic acid |
perfluorooctanoic acid results in increased expression of ACAD11 mRNA | increases expression | 18467677
|
C023036 |
perfluorooctanoic acid |
PPARA protein promotes the reaction [perfluorooctanoic acid results in increased expression of ACAD11 mRNA] | increases expression|increases reaction | 18467677
|
C006253 |
pirinixic acid |
[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of ACAD11 mRNA | affects binding|increases activity|increases expression | 19710929
|
C006253 |
pirinixic acid |
pirinixic acid results in increased expression of ACAD11 mRNA | increases expression | 18301758 17426115
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
3.38 | 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
2.03 | 20127859 20464547 |
MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
2.78 | 6695378 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
3.82 | 16434500 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
4.38 | 19183758 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
3.39 | 19483382 |
MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
2.01 | 17474063 20146248 |
MESH:D002252 |
Carbon Tetrachloride Poisoning |
|
Carbon Tetrachloride |
4.08 | 16192424 15700767 15673190 18705752 16227642 15721981 16050911 10355542 16097048 16124888 16011737 3786805 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,6-dinitrotoluene |
4.77 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Aflatoxin B1 |
4.77 | 12619106 12907637 21507988 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Carbon Tetrachloride |
4.77 | 18788625 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
2.10 | 20419170 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
2,6-dinitrotoluene |
7.11 | 6135515 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
7.11 | 12371664 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
8.35 | 19486331 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
8.35 | 19176532 |
MESH:D003490 |
Cyanosis |
|
2,6-dinitrotoluene |
4.32 | 18551238 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.52 | 18249437 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,6-dinitrotoluene |
4.08 | 21346803 18551238 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Carbon Tetrachloride |
4.08 | 7179309 19085960 10915739 7440962 15027814 16227642 2869522 17522070 6884620 6623471 10092053 15968718 9327722 15998439 21278145 4309450 19336974 16177239 3786805 11566570 7120509 3732212 |
MESH:D004487 |
Edema |
|
perfluorooctanoic acid |
7.79 | 12083418 17259670 |
MESH:D004487 |
Edema |
|
pirinixic acid |
7.79 | 12083418 |
MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
2.06 | 16530937 |
MESH:D005234 |
Fatty Liver |
|
Carbon Tetrachloride |
14.50 | 16045604 15959796 16239168 19224547 17595544 12795759 12631006 61145 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
14.50 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
14.50 | 19236843 20131406 |
MESH:D005355 |
Fibrosis |
|
Carbon Tetrachloride |
9.71 | 18705752 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
9.71 | 12168785 12639820 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.56 | 8708960 |
MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
2.77 | 20471113 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
2.67 | 20558911 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.76 | 15720958 |
MESH:D006505 |
Hepatitis |
|
Carbon Tetrachloride |
3.88 | 19110552 19900420 |
MESH:D006529 |
Hepatomegaly |
|
perfluorooctanoic acid |
9.74 | 3609246 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
9.74 | 19176532 18467677 16221962 19772884 |
MESH:D006930 |
Hyperalgesia |
|
perfluorooctanoic acid |
4.04 | 12083418 |
MESH:D006932 |
Hyperbilirubinemia |
|
Carbon Tetrachloride |
4.87 | 16899240 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.41 | 20558911 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
2.17 | 10903974 |
MESH:D006975 |
Hypertension, Portal |
|
Carbon Tetrachloride |
4.39 | 15338365 |
MESH:D007249 |
Inflammation |
|
perfluorooctanoic acid |
3.17 | 12083418 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
2.78 | 16306350 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.82 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
2.46 | 8314463 10903974 18776723 |
MESH:D007680 |
Kidney Neoplasms |
|
2,6-dinitrotoluene |
7.95 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
7.95 | 12371664 |
MESH:D007984 |
Leydig Cell Tumor |
|
perfluorooctanoic acid |
5.57 | 8812269 |
MESH:D008103 |
Liver Cirrhosis |
|
Carbon Tetrachloride |
2.92 | 16943688 16221502 11903743 17174718 17334410 16239168 11408273 17157831 21278145 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Carbon Tetrachloride |
2.38 | 17698563 15338365 18412020 12586293 12389079 16248980 12898905 12632514 14620537 18205269 18006644 15876570 15925388 18210741 14716496 12958196 18251166 17721639 12666154 12667390 17823541 18418968 18376398 18156304 14512876 18279442 15370692 16027843 17869086 17640975 18472332 15730626 17708605 12741479 17714472 10355542 12445418 18429990 16015684 12445421 18395914 17525996 15818738 15996030 17557913 17805973 17761835 15673190 12546737 13678700 18054572 18472094 17944888 18277467 17631135 11481614 20821823 18395095 14724832 18187930 18420326 14748882 17766677 17565644 12649538 18166357 15057751 17481882 15931870 16192424 15362042 16116963 18317297 18339082 12609069 15959796 18263696 15052691 17922224 16097048 16136751 16638106 17900296 18481824 17976157 15893842 15650968 16033810 18705752 16011737 12632512 14716833 15123356 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
2.38 | 15474484 |
MESH:D008107 |
Liver Diseases |
|
Carbon Tetrachloride |
2.13 | 15830285 16964402 15720792 17285989 16246199 |
MESH:D017093 |
Liver Failure |
|
Carbon Tetrachloride |
4.47 | 15123358 |
MESH:D017114 |
Liver Failure, Acute |
|
Carbon Tetrachloride |
3.92 | 14706259 16899240 |
MESH:D008113 |
Liver Neoplasms |
|
2,6-dinitrotoluene |
19.04 | 7678174 |
MESH:D008113 |
Liver Neoplasms |
|
Aflatoxin B1 |
19.04 | 2125692 15890375 18177683 9163691 |
MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
19.04 | 21137059 20195826 |
MESH:D008113 |
Liver Neoplasms |
|
Carbon Tetrachloride |
19.04 | 19294768 |
MESH:D008113 |
Liver Neoplasms |
|
perfluorooctanoic acid |
19.04 | 18709148 14757943 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
19.04 | 15890375 20007298 16377806 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
2,6-dinitrotoluene |
10.70 | 2876786 2876784 6135515 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Aflatoxin B1 |
10.70 | 8603461 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Carbon Tetrachloride |
10.70 | 12014681 15583823 |
MESH:D008175 |
Lung Neoplasms |
|
Aflatoxin B1 |
2.47 | 14755239 |
MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
2.47 | 6695378 18520028 18569708 17053015 20869020 20464547 18816296 20064080 20135361 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
5.16 | 16801185 |
MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
3.37 | 16381670 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.81 | 16239165 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
2.22 | 19151258 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
3.13 | 16411023 |
MESH:D009336 |
Necrosis |
|
2,6-dinitrotoluene |
4.20 | 18551238 7678174 |
MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
5.17 | 11141357 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
5.17 | 17405874 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.82 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.50 | 19348381 18481113 |
MESH:D052556 |
Niemann-Pick Disease, Type C |
|
perfluorooctanoic acid |
5.26 | 9802331 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
1.86 | 20558911 |
MESH:D009784 |
Occupational Diseases |
|
2,6-dinitrotoluene |
3.66 | 16049721 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
3.44 | 12371664 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
perfluorooctanoic acid |
4.73 | 17132714 |
MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
2.93 | 17292933 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.30 | 16882103 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.49 | 19058328 |
MESH:D012640 |
Seizures |
|
2,6-dinitrotoluene |
2.69 | 18551238 |
MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
2.46 | 19755658 10029692 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
1.56 | 2093021 20155912 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,6-dinitrotoluene |
5.24 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
5.24 | 17053015 |
MESH:D014571 |
Urologic Neoplasms |
|
2,6-dinitrotoluene |
4.66 | 10091137 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
4.36 | 1336536 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.82 | 17120751 |